Tablo Sales Boost Outset Bottom Line
Product revenues increased 5.5% and service revenues increased in Q3 of 2022 over 2021. The Tablo is used for acute and home HD, and Outset won a 5-year VA contract for Tablo in hospitals and homes.
Read the full article » | Posted 12-19-2022
Related Articles
- Fresenius ramps up supply of IV and PD fluids Posted 11-21-2024
- The International Society of Peritoneal Dialysis Celebrates 40 Years Posted 10-15-2024
- Michael Aragon, MD Article in DocWireNews on Switching from PD to Home HD Posted 10-15-2024
- PD Excellence Academy Offers Three New Courses and Up to 11 CE Credits Posted 09-12-2024